These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20797775)

  • 1. The role of restaging borderline ovarian tumors: single institution experience and review of the literature.
    Zapardiel I; Rosenberg P; Peiretti M; Zanagnolo V; Sanguineti F; Aletti G; Landoni F; Bocciolone L; Colombo N; Maggioni A
    Gynecol Oncol; 2010 Nov; 119(2):274-7. PubMed ID: 20797775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
    Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
    Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence and prognostic factors in borderline ovarian tumors.
    Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
    Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours.
    Querleu D; Papageorgiou T; Lambaudie E; Sonoda Y; Narducci F; LeBlanc E
    BJOG; 2003 Feb; 110(2):201-4. PubMed ID: 12618166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
    Anfinan N; Sait K; Ghatage P; Nation J; Chu P
    Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
    Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic restaging of borderline ovarian tumors.
    Daraï E; Tulpin L; Prugnolle H; Cortez A; Dubernard G
    Surg Endosc; 2007 Nov; 21(11):2039-43. PubMed ID: 17514402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
    Cho YH; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
    Gynecol Oncol; 2006 Dec; 103(3):878-82. PubMed ID: 16859736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors.
    Desfeux P; Camatte S; Chatellier G; Blanc B; Querleu D; Lécuru F
    Gynecol Oncol; 2005 Sep; 98(3):390-5. PubMed ID: 16043215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.
    Ramirez PT; Slomovitz BM; McQuinn L; Levenback C; Coleman RL
    Gynecol Oncol; 2006 Dec; 103(3):888-90. PubMed ID: 16806436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience.
    Leblanc E; Querleu D; Narducci F; Occelli B; Papageorgiou T; Sonoda Y
    Gynecol Oncol; 2004 Sep; 94(3):624-9. PubMed ID: 15350350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are borderline tumors of the ovary safely treated by laparoscopy?
    Maneo A; Vignali M; Chiari S; Colombo A; Mangioni C; Landoni F
    Gynecol Oncol; 2004 Aug; 94(2):387-92. PubMed ID: 15297177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome.
    Nezhat FR; Ezzati M; Chuang L; Shamshirsaz AA; Rahaman J; Gretz H
    Am J Obstet Gynecol; 2009 Jan; 200(1):83.e1-6. PubMed ID: 19019337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.